Teresa Byrne

Teresa is an experienced Clinical Research Executive, with more than 20 years of pharmaceutical industry experience from the research bench to the clinic. She has experience in both large pharmaceutical companies as well as in smaller biotech companies and CRO organisations.

Teresa has held clinical operations leadership roles at Janssen Research & Development (a Johnson & Johnson company), Novartis Vaccines, and GlaxoSmithKline. In addition, Teresa served as the Director of Clinical Quality Assurance for BioMotiv, a biotech accelerator.

Most recently, she lead Clinical Development for Cersci Therapeutics, a small biotech company acquired by Acadia Pharmaceuticals.

Teresa holds a Bachelor of Arts in Biology from Rutgers University, has done post-graduate work in clinical pharmacology at Thomas Jefferson University, and is a certified GCP auditor.